🦠 Measles is back. Cases have exploded in 2025 in France, UK, US & Europe due to falling vaccine coverage. The MMR vaccine is ~100% effective with 2 doses. It's saved 94M lives since 1974. Measles isn't just for kids – 34% of US cases were adults over 20. www.pasteur.fr/en/research-... #Measles

🌍 World AMR Awareness Week (#WAAW2025) 🎥 Dr Teske Schoffelen introduces the Abx Guide—a free, open-access database that compiles evidence on pathogen-directed antibiotic treatment. ▶️ Watch: youtu.be/XpN_fRG7pCk @heiman-wertheim.bsky.social @souhakanj.bsky.social

DON'T MISS IT! From Resistance to Resilience: healthcare workers leading the change. Join public health professionals, academia, patients' and NGO's representatives and let's talk about the ways to #KeepAntibioticsWorking! #EAAD2025 online event starts at 1PM CET! Register: bit.ly/EAAD2025Regi...

#Respiratory syncytial virus can cause severe illness especially in infants Data from Belgium, Portugal & Spain show that #immunisation of #children after birth with long-acting monoclonal antibodies 📉 the risk of #hospitalisation due to #RSV infection by ~80% #IDSky #EpiSky #PedSky #MedSky 🛟🧪

You can also find more information about #RSV on the European Vaccination Information Portal - #EVIP in YOUR language! Check it out here: vaccination-info.europa.eu/en/rsv #UnitedInProtection #VaccinesSaveLives #VaccinesWork #ChildHealth #PublicHealth

This winter, raising awareness among healthcare workers & following national recommendations will remain essential to reducing the burden of RSV on infants. Press release: bit.ly/4qSWLex Rapid scientific advice: bit.ly/4hTTNSG Living systematic review: bit.ly/4hVQLxz #IDsky #EpiSky

🛎️

🎓 Jetzt anmelden! Vom 01.–05.12.2025 bietet die Akademie des ZKS Köln wieder den Kurs für Studienkoordination an – als virtuelle Präsenzschulung. Für Study Nurses & Interessierte, die ins Studienmanagement einsteigen wollen. 👉 zks.uni-koeln.de/akademie/kurs-fuer-studienkoordination

📜 At #ESWI2025 Maria Zambon traces the history of how we understand pandemics — from religious interpretations to the rise of rational, evidence-based therapeutics A fascinating look at how science reshaped our view of disease and response🧠 #PublicHealth #Pandemic #History

Immunization against respiratory syncytial virus delivered to infants following birth is safe and provides high antibody levels, regardless of the mother’s RSV vaccination status, according to new research presented at #IDWeek2025. bit.ly/3J9fIbS

✈️ Next stop: #ESWI2025 in Valencia! We’re excited to join global experts in infectious disease control, antimicrobial stewardship, and vaccine innovation. Looking forward to sharing insights, forging collaborations, and advancing prevention together. #VIVI #InfectionPrevention

➡️ Pediatric myocarditis is more often viral and acute, adults more chronic and immune-mediated ➡️ Diagnosis and treatment draw from adult data, leaving major gaps in paediatric evidence CCR Journal Watch - tracking the critical care literature daily criticalcarereviews.com/latest-evide...

There are a few days left to apply for an ESCMID observership! ESCMID is awarding 50 young scientists up to 2K EUR to travel to one of the over 100 collaborative centres for knowledge exchange in the fields of CM & ID! Read more and apply before the deadline on Tuesday, 14 October: ow.ly/95BK50X2GRP

📣🧊 The Trainee Association of ESCMID (TAE) is holding elections for 3 new members in the steering committee. Young Scientist Members (YSM) and LMIC members fulfilling the YSM criteria are eligible to apply. Nominations close 31 October. ow.ly/fHsy50X96Nb

More than pills and shots — your gut microbiome might be a hidden key to vaccine success. 🌿 Recent research shows gut bacteria affect how well our bodies respond to #vaccines. Diet, probiotics, and microbiome health = new frontiers in prevention. #Microbiome #VIVI

Fantastic session on vaccine licensing covering aspects from fighting ongoing outbreaks, limited clinical data, and the current latest developments in the pipeline. Featuring Marco Cavaleri, Sarah Gilbert, Teresa Lambe and Annelies Wilder-Smith. @ema.europa.eu #VaccinesConference #Vaccines #IDSky

🌍 At @ESCMID #VaccinesConference in Lisbon, #Pandemic #Preparedness is in focus (Day 3 & Day 5). From surveillance to vaccines, global cooperation is key to staying ahead of future threats. Prevention today means resilience tomorrow. #UnitedInProtection 👉 bit.ly/ViVI-Prep2025

This week's rapid communications describe ➡️A strain of Neisseria gonorrhoeae producing false negative results on Xpert CT/NG assay in England 🔎An atypical sixfold rise in #influenza A(H1N1)pdm09 cases in Denmark during summer Full issue here 👉 bit.ly/eus2036 #EpiSky #IDSky #MedSky #STISky 🛟🦠🧫⚕️

#JeudiRétro | C’était la polio. Nous nous sommes fait vacciner. Éprouvés. Salvateurs. Les vaccins | www.immunize.ca/sites/defau... #polio #LesVaccinsÇaMarche #LesVaccinsSauventDesVies #FaitesVousVacciner

Welcome back students! Joining us from 29 different countries hailing from 6 continents across the various degree programs are: 72 PhD students, 15 SM1 students, 13 SM1 summer-only students, 62 SM2 students, and 76 MPH Epi students in the Department of Epidemiology @hsph.harvard.edu.

Response to Letter to the Editor, Re: The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study ✅ Just Accepted #IDSky

Ebola Virus Disease: Uniquely Challenging Among the Viral Hemorrhagic Fevers CCR Journal Watch - tracking the critical care literature daily https://criticalcarereviews.com/latest-evidence/journal-watch

Skin lesions and personal protective equipment (PPE) in healthcare workers from Lima, Peru during the COVID-19 pandemic: a cross-sectional study ✅ Just Accepted #IDSky

🧪 Just 1 week left to apply! ISAC Project Grants 2025 offer up to £15,000 for research in #AMR & #infectiousdiseases 🌍 Projects must involve 2 countries (1 LMIC) 📅 Deadline: 1 Sept 📧 [email protected] 🔗 isac.world #GlobalHealth #ISACGrants @heiman-wertheim.bsky.social @souhakanj.bsky.social

Stopping Spillover at the Source: #OneHealth Meets #Pandemic #Prevention 🛎️ A new roadmap in Emerging Infectious Diseases outlines how investigating and intercepting virus spillovers early—using integrated, cross‑sector efforts (One Health approach)—can help prevent future pandemics. #ActNow

Accurate measurement of viral clearance in early phase antiviral studies in COVID-19 ✅ Just Accepted #IDSky

The 715th Critical Care Reviews Newsletter is now out, covering the latest critical care publications from across the literature over the past week. Sample issue - https://criticalcarereviews.com/newsletters/sample-newsletter Subscribe at - https://criticalcarereviews.com/newsletters/subscribe

Advances in ischemic stroke treatment: current and future therapies CCR Journal Watch - tracking the critical care literature daily https://criticalcarereviews.com/latest-evidence/journal-watch

www.escmid-foundation.org/event-detail... We are pleased to announce this Postgraduate Course co-organised by: @escmid.bsky.social , #EIS, #ESGCIP, #ESGMD, #ESGIE, @esgphm.bsky.social, #EVASG, @esgrev-escmid.bsky.social and the #BIA; Sevilla, Spain, 21-23/10/25. Registration will close July 15.

Stay tuned for the next @ESCMID event! If you are working in vaccines and don’t want to wait until ESCMIDGlobal 2026 in Munich, then check out this vaccine conference in Lisbon in the fall this year.

Allez voir l’infographie créée par Immunisation Canada! | Les vaccins contre la coqueluche durant la #grossesse | immunize.ca/sites/defaul... #coqueluche #LesVaccinsÇaMarche #FaitesVousVacciner

The congress may be ending today but the content can be revisited in our #ESCMIDGlobal replay section. All scientific sessions can be watched or rewatched on the virtual congress platform available for 6 months: ow.ly/f6fP50VzPeU

Last chance at the Vienna Opera House-themed photobooth this year! Create light-hearted moments with colleagues & friends dressed as classical musicians on stage using a variety of entertaining props. #ESCMIDGlobal #IDSky #clinmicro

Kick off day 4 of #ESCMIDGlobal 2025 now in Hall 15! Join experts as they discuss how #climatechange is reshaping the landscape of #infectiousdiseases and the urgent need for adaptation strategies. See you there!

Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations - United States, September 1, 2023-May 31, 2024 ✅ Just Accepted ⭐ Editor's Choice #IDSky

Join Guy Thwaites at 16:15 CEST in Hall 1 at #ESCMIDGlobal 2025 for a deep dive into the current landscape of #tuberculosis treatment, exploring the urgent need for new clinical trials and the potential of host-directed therapies.

We are kicking off #ESCMIDGlobal 2025 with the brand-new #EducationFriday! Look forward to a day of educational sessions including special small group workshops covering all topics. Conclude the day by attending the #AMR Science-Policy Forum co-organised with the GLG! #IDSky #clinmicro #MedSky

#ESGREV has grown rapidly. We are proud of our new members. Please stay engaged and follow us on social media. Feel free to DM us with questions. Enjoy the remaining days of #ESCMIDGlobal and see you next year in Munich! @escmid.bsky.social @taescmid.bsky.social

Tissue-specific improvements in CD4+ T cell responses after treatment for visceral leishmaniasis. https://www.biorxiv.org/content/10.1101/2025.04.13.648617v1

Varicelle : ce qu’il faut savoir | Allez voir notre feuillet de renseignements informatif! | immunize.ca/sites/defaul... #varicelle #LesVaccinsÇaMarche #FaitesVousVacciner

Very Nice session @escmid.bsky.social on how micro may help improving infection Control measures. Educational session 💪🙏

The effect of pre-existing coronavirus antibodies on SARS-CoV-2 infection outcomes in exposed household members ✅ Just Accepted #IDSky

Allez voir notre collection de courtes vidéos sur #TikTok! www.tiktok.com/@immunizedot... #LesVaccinsÇaMarche #FaitesVousVacciner

Great day at the ESCMID Global 2025 in Vienna! Inspiring talks, impressive posters, and a strong presence from our team – proud of the great work and presentation. Looking forward to another exciting day tomorrow! #ESCMID2025 #Teamwork

Soon to come in Hall 16, don’t miss the session "Developing guidelines with AI tools: Are they ready for prime time?". Discover how #ArtificialIntelligence could transform the way we create patient-centered guidelines. Be there! #ESCMIDGlobal 2025.

Looking for the hot trials that may change your practice at #ESCMIDGlobal2025? Dr. @steventong.bsky.social has you covered as he shares findings from the #SNAP Trial 💊 Among 281 pts w/ PCN-susceptible S. aureus BSI, compared to flucloxacillin, benzylpenicillin had lower 90-day mortality & less AKI

Cost-Effectiveness of One-time Universal Testing for Hepatitis D among Adults living with Chronic Hepatitis B in the United States ✅ Just Accepted #IDSky

Following #EducationFriday, we are excited to open up #ESCMIDGlobal 2025 in full today! We hope you enjoy the start of the full congress today and we look forward to seeing you over the next four days in Vienna and online!

👉🏽Day 1 at ESCMID Global - what a great start! We had interesting conversations, looking forward to more connections tomorrow at Booth E70, Hall B. Don’t miss out some great sessions tomorrow such as 'New tools in acute bacterial infections and sepsis' presented by @lenniederde.bsky.social.